We are live on ! Find out more
OSCR icon

Oscar Health

332 hedge funds and large institutions have $3.61B invested in Oscar Health in 2025 Q2 according to their latest regulatory filings, with 94 funds opening new positions, 120 increasing their positions, 88 reducing their positions, and 52 closing their positions.

New
Increased
Maintained
Reduced
Closed

81% more first-time investments, than exits

New positions opened: 94 | Existing positions closed: 52

48% more capital invested

Capital invested by funds: $2.45B → $3.61B (+$1.17B)

43% more funds holding in top 10

Funds holding in top 10: 710 (+3)

36% more repeat investments, than reductions

Existing positions increased: 120 | Existing positions reduced: 88

14% more funds holding

Funds holding: 292332 (+40)

9% more call options, than puts

Call options by funds: $257M | Put options by funds: $236M

9.87% less ownership

Funds ownership: 86.79%76.92% (-9.9%)

Holders
332
Holders Change
+40
Holders Change %
+13.7%
% of All Funds
4.37%
Holding in Top 10
10
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+42.86%
% of All Funds
0.13%
New
94
Increased
120
Reduced
88
Closed
52
Calls
$257M
Puts
$236M
Net Calls
+$21.1M
Net Calls Change
+$4.21M
Name Holding Trade Value Shares
Change
Change in
Stake
TWD
326
True Wealth Design
Ohio
$236 +$15 +1 +10%
RWM
327
Rialto Wealth Management
New York
$193 +$134 +9 New
SC
328
SouthState Corp
Florida
$108 +$74 +5 New
HIA
329
HFM Investment Advisors
New Jersey
$107 -$30 -2 -29%
CWP
330
Clark Wealth Partners
Illinois
$64 +$45 +3 New
BHWM
331
Bay Harbor Wealth Management
Maryland
$42 +$15 +1 +100%
AA
332
Ancient Art
Texas
-$38.7M -2,950,753 Closed
Capital International Investors
333
Capital International Investors
California
-$31.8M -2,423,035 Closed
Holocene Advisors
334
Holocene Advisors
New York
-$17M -1,298,942 Closed
PWAM
335
Park West Asset Management
California
-$16.6M -1,263,973 Closed
GCM
336
Glenview Capital Management
New York
-$10.5M -798,981 Closed
Amundi
337
Amundi
France
-$9.08M -666,796 Closed
Qube Research & Technologies (QRT)
338
Qube Research & Technologies (QRT)
United Kingdom
-$7.7M -587,438 Closed
AGC
339
Aspen Grove Capital
Colorado
-$7.56M -577,027 Closed
FLAM
340
First Light Asset Management
Minnesota
-$6.85M -522,302 Closed
Adage Capital Partners
341
Adage Capital Partners
Massachusetts
-$6.73M -513,256 Closed
AAP
342
Ardsley Advisory Partners
Connecticut
-$4.59M -350,000 Closed
State of New Jersey Common Pension Fund D
343
State of New Jersey Common Pension Fund D
New Jersey
-$1.66M -126,687 Closed
MF
344
Magnetar Financial
Illinois
-$1.44M -109,977 Closed
CF
345
Corebridge Financial
Texas
-$1.31M -100,119 Closed
NRD
346
Nebula Research & Development
New York
-$1.25M -95,463 Closed
Toronto Dominion Bank
347
Toronto Dominion Bank
Ontario, Canada
-$983K -75,000 Closed
ACM
348
Aquatic Capital Management
Illinois
-$843K -64,279 Closed
1CM
349
1492 Capital Management
Wisconsin
-$816K -62,268 Closed
CAM
350
Cresset Asset Management
Illinois
-$762K -58,156 Closed

OSCR Hedge Fund Activity: Q2 2025 in Review

332 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Oscar Health (OSCR) for Q2 2025, worth a combined $3.61B — up 48% from $2.45B a quarter earlier.

Buyers outnumbered sellers: 94 funds opened new OSCR positions and 52 closed out — a net gain of 42 holders — while 120 added to existing stakes and 88 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $25.6M. The largest seller was Dragoneer Investment Group, cutting an estimated $82.8M.

  • 332 institutional investors held Oscar Health (OSCR) as of Q2 2025, up from 292 in Q1 2025.
  • Funds reported $3.61B of Oscar Health stock for Q2 2025, up 48% quarter-over-quarter.
  • 94 funds opened new Oscar Health positions in Q2 2025 and 52 closed out, a net change of +42 holders.
  • The largest Oscar Health buyer in Q2 2025 was Morgan Stanley, an estimated $25.6M added.
  • The largest Oscar Health seller in Q2 2025 was Dragoneer Investment Group, an estimated $82.8M sold.

Based on aggregated 13F filings for Q2 2025.